HKD 2.98
(-3.56%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -52.57 Million CNY | -127.36% |
2022 | 490.07 Million CNY | -9.77% |
2021 | 543.16 Million CNY | 47.91% |
2020 | 367.23 Million CNY | 2671.18% |
2019 | -14.28 Million HKD | 76.56% |
2018 | -60.94 Million HKD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -58.26 Million HKD | 8.79% |
2024 Q2 | -57.76 Million HKD | 0.15% |
2023 Q2 | 8.1 Million HKD | -5.52% |
2023 Q3 | -66.88 Million HKD | -925.68% |
2023 FY | -134.06 Million CNY | -127.36% |
2023 Q4 | -65.14 Million HKD | 2.59% |
2023 Q1 | 8.57 Million HKD | -90.1% |
2022 Q3 | 84.42 Million HKD | -75.25% |
2022 FY | 490.07 Million CNY | -9.77% |
2022 Q4 | 86.59 Million HKD | 2.58% |
2022 Q2 | 341.06 Million HKD | 0.0% |
2021 FY | 543.16 Million CNY | 47.91% |
2020 FY | 367.23 Million CNY | 2671.18% |
2019 FY | -14.28 Million HKD | 76.56% |
2018 FY | -60.94 Million HKD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Life Healthcare Group Limited | 17.63 Million HKD | 398.151% |
China Biotech Services Holdings Limited | -127.67 Million HKD | 58.82% |